Back to search
FDAFDA · Food and drugs·Recall number D-0157-2027

Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK, Manufactured for: AvKARE, Pulaski, TN 38748, NDC 50268-330-15

Published November 11, 2026 · Recall initiated: October 9, 2026

Summary

FDA records drug Class II recall D-0157-2027, published November 11, 2026 and initiated October 9, 2026. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 8866 cartons; Lot: Lot # 48353; Exp. 10/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if FLUDROCORTISONE ACETATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FLUDROCORTISONE ACETATE
Manufacturer
AvKARE
Distributor
U.S. Nationwide
Lot
Lot # 48353; Exp. 10/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 50 Tablets (5 x 10) Unit Dose AVPAK, Manufactured for: AvKARE, Pulaski, TN 38748, NDC 50268-330-15 recalled?

Yes. FDA published recall D-0157-2027 on November 11, 2026. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FLUDROCORTISONE ACETATE.